Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Quantification of cytomeg… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Quantification of cytomegalovirus DNA in BAL fluid: a longitudinal study in lung transplant recipients

Artikel i vetenskaplig tidskrift
Författare Gerdt C. Riise
Rune Andersson
Tomas Bergström
Agnete Lundmark
Folke Nilsson
Sigvard Olofsson
Publicerad i Chest
Volym 118
Nummer/häfte 6
Sidor 1653-60
ISSN 0012-3692 (Print)
Publiceringsår 2000
Publicerad vid Institutionen för de kirurgiska disciplinerna
Institutionen för invärtesmedicin, Avdelningen för infektionssjukdomar
Institutionen för invärtesmedicin, Avdelningen för lungmedicin och allergologi
Institutionen för laboratoriemedicin, Avdelningen för klinisk virologi
Sidor 1653-60
Språk en
Länkar www.ncbi.nlm.nih.gov/entrez/query.f...
Ämnesord Adult, Bronchoalveolar Lavage Fluid/cytology/*virology, Cytomegalovirus/*isolation & purification, Cytomegalovirus Infections/diagnosis, DNA, Viral/*analysis, Female, Graft Rejection, Humans, Immunosuppression, Longitudinal Studies, *Lung Transplantation/adverse effects, Male, Middle Aged, Polymerase Chain Reaction, Viral Load
Ämneskategorier Dermatologi och venereologi

Sammanfattning

STUDY OBJECTIVES: Cytomegalovirus (CMV) infection is common in patients receiving solid organ transplants, and it is associated with increased morbidity as well as risk for development of chronic rejection. A rapid and sensitive diagnostic method would improve the therapeutic management of CMV infection, including the monitoring of treatment effects. We investigated whether longitudinal determinations of CMV DNA quantities in BAL fluid could be useful for this purpose. DESIGN: CMV DNA levels in 340 BAL samples from 35 consecutive lung transplant recipients were studied during a median of 18 months. Seventeen (49%) of the patients developed CMV disease with pneumonitis. Twenty-seven CMV disease episodes were diagnosed. RESULTS: Patients with CMV disease had a significantly higher mean level of CMV copies per milliliter BAL fluid (1,120 +/- 4,379) compared with those without (180 +/- 1,177, p < 0.01). Viral load as well as acute rejection requiring treatment (>/= A2) were independent risk factors associated with CMV disease. Differences between the groups concerning HLA-DR matching, basic immunosuppressive therapy, and CMV serologic status D/R -/+ vs D/R +/+ were not significant. A diagnostic definition of normality based on the mean level of all episodes without CMV disease +2 SD would discriminate only 9 of the 27 CMV episodes. CONCLUSIONS: Although the viral load is increased during episodes of clinical CMV disease in lung transplant recipients, the quantitative PCR assessment of CMV DNA in BAL fluid is not discriminative enough to be useful as a diagnostic tool for CMV disease.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?